President and Fellows of Harvard College;The General Hospital Corporation
发明人:
Amir Schajnovitz,David T. Scadden
申请号：
US15130623
公开号：
US20160367578A1
申请日:
2016.04.15
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The disclosure relates to compositions, methods, and kits comprising glycyrrhetinic acid derivatives for selectively eradicating leukemic cells in a population or subject, and related methods of treating acute myeloid leukemia, and promoting survival of acute myeloid leukemia patients.
